Here, we successfully conducted single cell RNA-sequencing analysis to tumor specimens from NSCLC patients with pathologically confirmed lung adenocarcinoma (LUAD) or NSCLC and progressed on EGFR-TKIs treatment, which was illustrated in Figure 4A. This evidence concerns the gene EGFR and neoplasm.